Skip to main content
Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
9.53
+0.20 (2.09%)
Nov 21, 2024, 11:59 AM EST - Market open

Immunome Revenue

Immunome had revenue of $2.91M in the quarter ending September 30, 2024, a decrease of -18.37%. This brings the company's revenue in the last twelve months to $10.13M, down -0.62% year-over-year. In the year 2023, Immunome had annual revenue of $14.02M.

Revenue (ttm)
$10.13M
Revenue Growth
-0.62%
P/S Ratio
49.40
Revenue / Employee
$184,164
Employees
55
Market Cap
594.52M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202314.02M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Varex Imaging 832.70M
OrthoPediatrics 189.67M
Standard BioTools 155.90M
Butterfly Network 76.22M
CureVac 70.57M
AnaptysBio 57.17M
ABIVAX Société Anonyme 9.68M
IGM Biosciences 2.92M
Revenue Rankings

IMNM News

More News